Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 3, 2007 - Issue 3
Submit an article Journal homepage
250
Views
112
CrossRef citations to date
0
Altmetric
Review

Natural polyphenol disposition via coupled metabolic pathways

Zhongqiu Liu Hong Kong Baptist University, School of Chinese Medicine, Hong Kong, China; Southern Medical University, Department of Pharmaceutics, College of Pharmacy, Guangzhou, 510515, China
&
Ming Hu University of Houston, Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, Houston, TX 77030, USA
Pages 389-406 | Published online: 31 May 2007

Bibliography

  • MEYER UA: Overview of enzymes of drug metabolism. J. Pharmacokinet. Biopharm. (1996) 24(5):449-459.
  • WANG H, LECLUYSE EL: Role of orphan nuclear receptors in the regulation of drug-metabolizing enzymes. Clin. Pharmacokinet. (2003) 42(15):1331-1357.
  • BANOGLU E: Current status of the cytosolic sulfotransferases in the metabolic activation of promutagens and procarcinogens. Curr. Drug Metab. (2000) 1(1):1-30.
  • INNOCENTI F, GRIMSLEY C, DAS S etal.: Haplotype structure of the UDP-glucuronosyltransferases 1A1 promoter in different ethnic groups. Pharmacogenetics (2002) 12:725-733.
  • MANDLEKAR S, HONG JL, KONG AN: Modulation of metabolic enzymes by dietary phytochemicals: a review of mechanisms underlying beneficial versus unfavorable effects. Curr.Drug Metab. (2006) 7(6):661-675.
  • BRINKMANN U, EICHELBAUM M: Polymorphisms in the ABC transporter gene MDR1. Pharmacogenomics J. (2001) 1:59-64.
  • MARZOLINI C TIRONA RG KIM RB: Pharmacogenomics of the OATP and OAT families. Pharmacogenomics (2004) 5(3):273-82.
  • KERB R, HOFFMEYER S, BRINKMANN U: ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2. Pharmacogenomics (2001) 2(1):51-64.
  • MIZUNO N, NIWA T, YOTSUMOTO Y etal.: Impact of drug transporter studies on drug discovery and development. Pharmcol. Rev. (2003) 55:425-461.
  • HARNLY JM, DOHERTY RF, BEECHER GR etal.: Flavonoid content of US Fruits, vegetables, and nuts. J. Agric. Food Chem. (2006) 54(26):9966-9977.
  • FRESCO P, BORGES F, DINIZ C etal.: New insights on the anticancer properties of dietary polyphenols. Med. Res.Rev. (2006) 26(6):747-766.
  • RAMASSAMY C: Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. Eur. J. Pharmacol. (2006) 545(1):51-64.
  • CASSIDY A: Factors affecting the bioavailability of soy isoflavones in humans. J.AOAC Int. (2006) 89(4):1182-1188.
  • WHITSETT TG JR, LAMARTINIERE CA: Genistein and resveratrol: mammary cancer chemoprevention and mechanisms of action in the rat. Expert Rev. Anticancer Ther. (2006) 6(12):1699-1706.
  • SHARMA RA, GESCHER AJ, STEWARD WP: Curcumin: the story so far. Eur. J. Cancer (2005) 41(13):1955-1968.
  • CABRERA C, ARTACHO R, GIMENEZ R: Beneficial effects of green tea – a review. J. Am. Coll. Nutr. (2006) 25(2):79-99.
  • ADLERCREUTZ H, HONJO H HIGASHI A et al.: Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am. J. Clin. Nutr. (1991) 54(6):1093-1100.
  • BOUKER KB, HILAKIVI-CLARKE L: Genistein: does it prevent or promote breast cancer? Environ. Health Perspect. (2000) 108(8):701-708.
  • SCHAFFER S, ECKERT GP, SCHMITT-SCHILLIG S etal.: Plant foods and brain aging: a critical appraisal. Forum Nutr. (2006) 59:86-115.
  • BREINHOLT V, HOSSAINI A, SVENDSEN GW etal.: Estrogenic activity of flavonoids in mice. The importance of estrogen receptor distribution, metabolism and bioavailability. Food Chem.Toxicol. (2000) 38(7):555-564.
  • BENGMARK S: Impact of nutrition on aging and disease. Curr. Opin. Clin. Nutr. Metab. Care (2006) 9(1):2-7.
  • WILLIAMSON G, MANACH C: Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am. J. Clin. Nutr. (2005) 81(Suppl. 1):243S-255S.
  • MANACH C, WILLIAMSON G, MORAND C etal.: Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. (2005) 81(Suppl. 1):230S-242S.
  • SCALBERT A, WILLIAMSON G: Dietary intake and bioavailability of polyphenols. J. Nutr. (2000) 130(Suppl. 8S):2073S-2085S.
  • DAY AJ, Williamson G: Biomarkers for exposure to dietary flavonoids: a review of the current evidence for identification of quercetin glycosides in plasma. Br. J. Nutr. (2001) 86(Suppl. 1):S105-S110.
  • HOLLMAN PC, VAN TRIJP JM, BUYSMAN MN etal.: Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett. (1997) 418(1-2):152-156.
  • DONOVAN JL, BELL JR, KASIM-KARAKAS S etal.: Catechin is present as metabolites in human plasma after consumption of red wine. J. Nutr. (1999) 129(9):1662-1668.
  • SETCHELL KD, BROWN NM, DESAI P etal.: Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J. Nutr. (2001) 131(Suppl. 4):1362S-1375S.
  • RAPAKA RS, COATES PM: Dietary supplements and related products: a brief summary. Life Sci. (2006) 78(18):2026-2032.
  • TSUDA T, HORIO F, OSAWA T: Absorption and metabolism of cyanidin 3-O-β-d-glucoside in rats. FEBS Lett. (1999) 449:179-182.
  • WU X, CAO G, PRIOR RL: Absorption and metabolism of anthocyanins in elderly women after consumption of elderberry or blueberry. J. Nutr. (2002) 132(7):1865-1871.
  • PASSAMONTI S, VRHOVSEK U, VANZO A etal.: The stomach as a site for anthocyanins absorption from food. FEBS Lett. (2003) 544:210-213.
  • GUGLER R, LESCHIK M, DENGLER HJ: Disposition of quercetin in man after single oral and intravenous doses. Eur. J. Clin. Pharmacol. (1975) 9(2-3):229-234.
  • HOLLMAN PC, DE VRES JH, VAN LEEUWEN SD etal.: Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr. (1995) 62(6):1276-1282.
  • ERLUND I, KOSONEN T, ALFTHAN G etal.: Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur. J. Clin. Pharmacol. (2000) 56(8):545-553.
  • GRAEFE EU, QITTING J, MUELLUER S etal.: Pharmacokinetics and bioavailability of quercetin aglycone and rutin in humans. J. Clin. Pharmacol. (2001) 41:492-499.
  • DAY AJ, MELLON F, BARRON D etal.: Human metabolism of dietary flavonoids: identification of plasma metabolites of qucercetin. Free Radic.Res. (2001) 35(6):941-942.
  • MANTHEY JA, GROHMANN K: Phenols in citrus peel byproducts. Concentrations of hydroxycinnamates and polymethoxylated flavones in citrus peel molasses.J. Agric. Food Chem. (2001) 49(7):3268-3273.
  • BUGIANESI R, CATASTA G, SPIGNO P etal.: Naringenin from cooked tomato paste is bioavailable in men. J. Nutr. (2002) 132(11):3349-3352.
  • MANACH C, MORAND C, GIL-IZQUIERDO A etal.: Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur. J. Clin. Nutr. (2003) 57(2):235-242.
  • ERLUND I, SILASTE ML, ALFTHAN G et al.: Plasma concentrations of the flavonoids hesperetin, naringenin and quercetin in human subjects following their habitual diets, and diets high or low in fruit and vegetables. Eur. J. Clin. Nutr. (2002) 56(9):891-898.
  • IZUMI T, PISKULA MK, OSAWA S etal.: Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J. Nutr. (2000) 130(7):1695-1699.
  • SETCHELL KD, BROWN NM, DESAI P etal.: Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J. Nutr. (2003) 133(4):1027-1035.
  • ZUBIK L, MEYDANI M: Bioavailability of soybean isoflavone from aglycone and glucoside forms in American women. Am. J. Clin. Nutr. (2003) 77(6):1459-1465.
  • SETCHELL KD, BROWN NM, LYDEKING-OLSEN E: The clinical importance of the metabolite equol – a clue to the effectiveness of soy and its isoflavones. J. Nutr. (2002) 132(12):3577-3584.
  • SETCHELL KD, BROWN NM, ZIMMER-NECHEMIAS L etal.: Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am. J. Clin. Nutr. (2002) 76(2):447-453.
  • DOERGE DR, CHANG HC, CHURCHWELL MI etal.: Analysis of soy isoflavone conjugation invitro and in human blood using liquid chromatography-mass spectrometry. Drug Metab. Dispos. (2000) 28(3):298-307.
  • SHELNUTT SR, CIMINO CO, WIGGINS PA etal.: Pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein in men and women after consumption of a soy beverage. Am. J. Clin. Nutr. (2002) 76(3):588-594.
  • CLARKE DB, LLOYD AS, BOTTING NP etal.: Measurement of intact sulfate and glucuronide phytoestrogen conjugates in human urine using isotope dilution liquid chromatography-tandem mass spectrometry with [13C(3)]isoflavone internal standards. Anal. Biochem. (2002) 309(1):158-172.
  • BAUR JA, SINCLAIR DA: Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. (2006) 5(6):493-506.
  • ROUPE KA, YANEZ JA, TENG XW: Pharmacokinetics of selected stilbenes: rhapontigenin, piceatannol and pinosylvin in rats. J. Pharm. Pharmacol. (2006) 58(11):1443-1450.
  • THOMAS HR, KONG ANT: Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr. Drug Metab. (2002) 3(5):481-490.
  • CAMPBELL TC.: Nutrition and drug-metabolizing enzymes. Clin. Pharmacol. Ther. (1977) 5(Pt 2):699-706.
  • CUPP MJ, TRACY TS.: Cytochrome P450: new nomenclature and clinical implications. Am. Fam. Physician (1998) 57(1):107-116.
  • WU AH, YU MC, TSENG CC, TWADDLE NC, DOERGE DR: Plasma isoflavone levels versus self-reported soy isoflavone levels in Asian-American women in Los Angeles County. Carcinogenesis (2004) 25(1):77-81.
  • STEENSMA A, FAASSEN-PETERS MA, NOTEBORN HP etal.: Bioavailability of genistein and its glycoside genistin as measured in the portal vein of freely moving unanesthetized rats. J. Agric. Food Chem. (2006) 54(21):8006-8012.
  • KING RA, BURSILL DB: Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am. J. Clin. Nutr. (1998) 67:867-872.
  • XU X, WANG HJ, MURPHY PA etal.: Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J. Nutr. (1994) 124(6):825-832.
  • WATANABE S, YAMAGUCHI M, SOBUE T etal.: Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). J. Nutr. (1998) 128(10):1710-1715.
  • RONIS MJ, LITTLE JM, BARONE GW etal.: Sulfation of the isoflavones genistein and daidzein in human and rat liver and gastrointestinal tract. J. Med. Food (2006) 9(3):348-355.
  • GU L, HOUSE SE, PRIOR RL etal.: Metabolic phenotype of isoflavones differ among female rats, pigs, monkeys, and women. J. Nutr. (2006) 136(5):1215-1221.
  • WENZEL E, SOMOZA V: Metabolism and bioavailability of trans-resveratrol. Mol. Nutr. Food Res. (2005) 49(5):472-481.
  • JEONG EJ, JIA X, HU M: Disposition of formononetin via enteric recycling: metabolism and excretion in mouse intestinal perfusion and Caco-2 cell models. Mol.Pharm. (2005) 2(4):319-328.
  • COOKE D, STEWARD WP, GESCHER AJ et al.: Anthocyans from fruits and vegetables – does bright colour signal cancer chemopreventive activity? Eur. J. Cancer (2005) 41(13):1931-1940.
  • SCAlBERT A, WILLIAMSON G: Dietary intake and bioavailability of polyphenols. J. Nutr. (2000) 130:2073S-2085S.
  • DELL’ AGLI M, BUSCIALA A, BOSISO E: Vascular effects of wine polyphenols. Cardiovasc. Res. (2004) 63(4):593-602.
  • FUJIKI H, SUGANUMA M, OKABE S et al.: Mechanistic findings of green tea as cancer preventive for humans. Proc. Soc. Exp. Biol. Med. (1999) 220(4):225-228.
  • THOMASSET SC, BERRY DP, GARCEA G: Dietary polyphenolic phytochemicals – promising cancer chemopreventive agents in humans? A review of their clinical properties. Int. J. Cancer (2007) 120(3):451-458.
  • MENNEN LI, WALKER R, BENNETAU-PELISSERO C et al.: Risks and safety of polyphenol consumption. Am. J. Clin. Nutr. (2005) 81(1 Suppl.):326S-329S.
  • ZIJP IM, KORVER O, TIJBURG LBM: Effect of tea and other dietary factors on iron absorption. Crit. Rev. Food Sci. Nutr. (2000) 40:371-98.
  • VERONESE ML, GILLEN LP, BURKE JP et al.: Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice. J. Clin. Pharmacol. (2003) 43:831-839.
  • AMEER B, WEINTRAUB RA: Drug interactions with grapefruit juice. Clin. Pharmacokinet. (1997) 33:103-121.
  • WANG Q, MORRIS ME: Flavonoids modulate monocarboxylate transporter-1-mediated transport of gamma-hydroxybutyrate in vitro and in vivo. Drug Metab. Dispos. (2007) 35(2):201-208.
  • MANACH C, SCALBERT A, MORAND C etal.: Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. (2004) 79(5):727-747.
  • CHEN J, LIN H, HU M: Absorption and metabolism of genistein and its isoflavone analogs in human intestinal Caco-2 cells. Cancer Chemother. Pharmacol. (2004) 55(2):1591-1569.
  • KUHNLE G, SPENCER JP, SCHROETER H et al.: Epicatechin and catechin are O-methylated and glucuronidated in the small intestine. Biochem. Biophys. Res. Commun. (2000) 277(2):507-512.
  • LIU Y, LIU Y, DAI Y etal.: Enteric disposition and recycling of flavonoids and ginkgo flavonoids. J. Altern. Complement. Med. (2003) 9:631-640.
  • SPENCER JP, CHOWRIMOOTOO G, CHOUDHURY R etal.: The small intestine can both absorb and glucuronidate luminal flavonoids. FEBS Lett. (1999) 458(2):224-230.
  • BOERSMA MG, VAN DER WOUDE H, BOGAARDS J etal.: Regioselectivity of Phase II metabolism of luteolin and quercetin by UDP-glucuronosyltransferases. Chem. Res. Toxicol. (2002) 15(5):662-670.
  • O’ LEARY KA, DAY AJ, NEEDS PW et al.: Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: the role of human beta-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochem. Pharmacol. (2003) 65(3):479-491.
  • ZHU BT, PATEL UK, CAI MX etal.: O-Methylation of tea polyphenols catalyzed by human placental cytosolic catechol-O-methyltransferase. Drug Metab. Dispos. (2000) 28(9):1024-1030.
  • GOLDBERG DM, YAN J, SOLEAS GJ: Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem. (2003) 36(1):79-87.
  • WU AH, TSENG CC, VAN DEN BERG D etal.: Tea intake, COMT genotype, and breast cancer in Asian-American women. Cancer Res. (2003) 63(21):7526-7529.
  • LEE WJ, SHIM JY, ZHU BT: Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol. Pharmacol. (2005) 68(4):1018-1030.
  • NAKAJIMA M, ITOH M, YAMANAKA H etal.: Isoflavones inhibit nicotine C-oxidation catalyzed by human CYP2A6. J. Clin. Pharmacol. (2006) 46(3):337-644.
  • ROBERTS DW, DOERGE DR, CHURCHWELL MI etal.: Inhibition of extrahepatic human cytochromes P450 1A1 and 1B1 by metabolism of isoflavones found in Trifolium pratense (red clover). J. Agric. Food Chem. (2004) 52(21):6623-6632.
  • TOLLESON WH, DOERGE DR, CHURCHWELL MI etal.: Metabolism of biochanin A and formononetin by human liver microsomes invitro. J. Agric. Food Chem. (2002) 50(17):4783-4790.
  • PAL D, MITRA AK: MDR- and CYP3A4-mediated drug-herbal interactions. Life Sci. (2006) 78(18):2131-2145.
  • MOON YJ, WANG X, MORRIS ME: Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol. InVitro (2006) 20(2):187-210.
  • JEONG EJ, LIU X, JIA X etal.: Coupling of conjugating enzymes and efflux transporters : impact on bioavailability and drug interactions. Curr. Drug Metab. (2005) 6(5):455-468.
  • DAY AJ, CANADA FJ, DIAZ JC etal.: Dietary flavonoids and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett. (2000) 468(2-3):166-170.
  • SESINK AL, ARTS IC, FAASSEN-PETERS M etal.: Intestinal uptake of quercetin-3-glucoside in rats involves hydrolysis by lactase phlorizin hydrolase. J. Nutr. (2003) 133(3):773-776.
  • ATKINSON C, FRANKENFELD CL, LAMPE JW: Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp.Biol.Med. (2005) 230(3):155-170.
  • WANG SW, CHEN J, JIA X et al.: Disposition of flavonoids via enteric recycling: structural effects and lack of correlations between in vitro and in situ metabolic properties. Drug Metab.Dispos. (2006) 34(11):1837-1848.
  • VERGNE S, TITIERK, BERNARD V et al.: Bioavailability and urinary excretion of isoflavones in humans: effects of soy-based supplements formulation and equol production. J. Pharm. Biomed. Anal. (2007) 43(4):1488-1494.
  • SETCHELL KD, FAUGHNAN MS, AVADES T etal.: Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labled tracers in premenopausal women. Am. J. Clin. Nutr. (2003) 77(2):411-419.
  • LIU Y, HU M: Absorption and metabolism of flavonoids in the Caco-2 cell culture model and a perfused rat intestinal model. Drug Metab. Dispos. (2002) 30(4):370-377.
  • CHAN LM, LOWES S, HIRST BH: The ABCs of drug transport of drugs and nutrients: genomics of membrane transporters using expression microarrays. Eur. J. Pharm. Sci. (2004) 21(1):25-51.
  • CHEN J, WANG S, JIA X et al.: Disposition of flavonoids via recycling: comparison of intestinal versus hepatic disposition. Drug Metab. Dispos. (2005) 33(12):1777-1784.
  • COLDHAM NG, SAUER MJ: Pharmacokinetics of [14C] genistein in the rat: gender-related differences, potential mechanisms of biological action, and implications for human health. Toxicol. Appl. Pharmacol. (2000) 164(2):206-215.
  • CRESPY V, MORAND C, BESSON C etal.: Comparison of the intestinal absorption of quercetin, phloretin and their glucosides in rats. J. Nutr. (2001) 131(8):2109-2114.
  • YE Z, RENOUF M, LEE SO et al.: High urinary isoflavone excretion phenotype decreases plasma cholesterol in golden Syrian hamsters fed soy protein. J. Nutr. (2006) 136(11):2773-2778.
  • CUMMINS CL, JACOBSEN W, BENET LZ: Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4. Pharmacol. Exp. Ther. (2002) 300(3):1036-1045.
  • BENET LZ, CUMMINS CL: The drug-metabolism alliance: biochemical aspects. Adv. Drug Deliv. Rev. (2001) 50(1 Suppl.):S3-S11.
  • TIRONA RG, LEALE BF, WOLKOFF AW etal.: Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation. J. Pharmacol. Exp. Ther. (2003) 304(1):223-228.
  • LIU Y, HU M: P-glycoprotein and bioavailability – implication of polymorphism. Clin. Chem. Lab Med. (2000) 38(9):877-881.
  • CHEN J, LIN H, HU M: Metabolism of flavonoids via enteric recycling: role of intestinal disposition. J. Pharmacol. Exp. Ther. (2003) 304(3):1228-1235.
  • KELLETT GL, BROT-LAROCHE E: Apical GLUT2: a major pathway of intestinal sugar absorption. Diabetes (2005) 54(10):3056-3062.
  • HOSSAIN SJ, KATO H, AOSHIMA H et al.: Polyphenol-induced inhibition of the response of na(+)/glucose cotransporter expressed in Xenopus oocytes. J. Agric. Food Chem. (2002) 50(18):5215-5219.
  • ZHANG Y, HENDRICH S, MURPHY PA et al.: Glucuronides are the main isoflavone metabolites in women. J. Nutr. (2003) 133(2):399-404.
  • JIA X, CHEN J, LIN H etal.: Disposition of flavonoids via enteric recycling: metabolism and excretion of two red clover isoflavones biochanin A and formononetin. J. Pharmacol. Exp. Ther. (2004) 310(3):1103-1113.
  • HU M, CHEN J, LIN H: Disposition of flavonoids via recycling: mechanistic studies of disposition of apigenin in the Caco-2 cell culture model. Pharmacol. Exp. Ther. (2003) 307(1):314-321.
  • YEH CT, YEN GC: Effect of vegetables on human phenolsulfotransferases in relation to their antioxidant activity and total phenolics. Free Radic.Res. (2005) 39(8):893-904.
  • GOTOH Y, SUZUKI H, KINOSHITA S etal.: Involvement of an orgainic anion transporter (canalicular multispecific organic anion transporter/multidrug resistance-associated protein 2) in gastrointestinal secretion of glutathione conjugates in rats. J. Pharmacol. Exp. Ther. (2000) 292(1):433-439.
  • FABER KN, MILLER M, JANSEN PL etal.: Drug efflux transporters in the liver. Adv. Drug Deliv. Rev. (2003) 55(1):107-124.
  • WALLE T, OTAKE Y, BRUBAKER JA etal.: Disposition and metabolism of the flavonoid chrysin in normal volunteers. Br. J. Clin. Pharmacol. (2001) 51(2):143-146.
  • UENO I, NAKANO N, HIRONO I: Metabolic fate of [14C] quercetin in the ACI rat. Jpn J. Exp. Med. (1983) 53(1):41-50.
  • SUGANUMA M, OKABE S, ONIYAMA M etal.: Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis (1998) 19(10):1771-1176.
  • MULLEN W, GRAF BA, CALDWELL ST etal.: Determination of flavonol metabolites in plasma and tissue of rats by HPLC-radiocounting and tandem mass spectrometry following oral ingestion of [2-(14)C] quercetin-4′-glucoside. J. Agric. Food Chem. (2002) 50(23):6902-6909.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.